Molecular network study of pituitary adenomas

Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that occur in the central regulatory organ pituitary, which plays important roles in the hypothalamus-pituitary-targeted organ axis systems that impact on important physiological functions of human body. Rapidly devel...

Full description

Saved in:
Bibliographic Details
Other Authors: Zhan, Xianquan (Editor), Desiderio, Dominic M. (Editor)
Format: Book Chapter
Published: Frontiers Media SA 2020
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02906naaaa2200409uu 4500
001 doab_20_500_12854_73744
005 20211118
020 |a 978-2-88963-602-0 
020 |a 9782889636020 
024 7 |a 10.3389/978-2-88963-602-0  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJG  |2 bicssc 
100 1 |a Zhan, Xianquan  |4 edt 
700 1 |a Desiderio, Dominic M.  |4 edt 
700 1 |a Zhan, Xianquan  |4 oth 
700 1 |a Desiderio, Dominic M.  |4 oth 
245 1 0 |a Molecular network study of pituitary adenomas 
260 |b Frontiers Media SA  |c 2020 
300 |a 1 electronic resource (210 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that occur in the central regulatory organ pituitary, which plays important roles in the hypothalamus-pituitary-targeted organ axis systems that impact on important physiological functions of human body. Rapidly developed multi-omics and systems biology are impacting on treatment of pituitary adenomas and changing the paradigms from the traditional single-factor strategy to a multi-parameter systematic strategy. A series of molecular alterations at different levels of genes (genome), RNAs (transcriptome), proteins (proteome), peptides (peptidome), metabolites (metabolome), and imaging characteristics (radiome) that resulted from exogenous and endogenous carcinogens are involved in pituitary tumorigenesis and mutually associate and function in a molecular network system, thus determines the difficulty in the use of a single molecule as biomarker to clarify its molecular mechanisms, and to predict, prevent, diagnose, and treat a pituitary adenoma. Of them, molecular network study plays central roles. A key molecule-panel biomarker that is derived from molecular network is necessary for accurately clinical practice of a pituitary adenoma. The modern multi-omics, computation biology, and systems biology technologies lead to the possibility in recognizing really reliable molecular-panel biomarker for research and clinical practice in pituitary adenomas. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Endocrinology  |2 bicssc 
653 |a pituitary adenoma 
653 |a signaling pathway 
653 |a molecular network 
653 |a multi-omics 
653 |a personalized medicine 
653 |a precision medicine 
653 |a therapeutic target 
653 |a molecule-panel biomarker 
856 4 0 |a www.oapen.org  |u https://www.frontiersin.org/research-topics/7633/molecular-network-study-of-pituitary-adenomas  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/73744  |7 0  |z DOAB: description of the publication